Your browser doesn't support javascript.
loading
Industry Perspective on Contemporary Protein-Binding Methodologies: Considerations for Regulatory Drug-Drug Interaction and Related Guidelines on Highly Bound Drugs.
Di, Li; Breen, Christopher; Chambers, Rob; Eckley, Sean T; Fricke, Robert; Ghosh, Avijit; Harradine, Paul; Kalvass, J Cory; Ho, Stacy; Lee, Caroline A; Marathe, Punit; Perkins, Everett J; Qian, Mark; Tse, Susanna; Yan, Zhengyin; Zamek-Gliszczynski, Maciej J.
Afiliación
  • Di L; Pfizer Inc., Groton, Connecticut 06340. Electronic address: li.di@pfizer.com.
  • Breen C; Novartis, East Hanover, New Jersey 07936.
  • Chambers R; GlaxoSmithKline, Ware, United Kingdom.
  • Eckley ST; Eisai Inc., Andover, Massachussetts 01810.
  • Fricke R; Bayer AG, Wuppertal, Germany.
  • Ghosh A; Janssen, Spring House, Pennsylvania 19477.
  • Harradine P; Merck & Co. Inc., Kenilworth, New Jersey 07033.
  • Kalvass JC; AbbVie, North Chicago, Illinois 60064.
  • Ho S; Sanofi, Waltham, Massachussetts 02451.
  • Lee CA; Ardea Biosciences, An Astra-Zeneca Company, San Diego, California 92121.
  • Marathe P; Bristol Myers-Squibb, Princeton, New Jersey 08540.
  • Perkins EJ; Eli Lilly, Indianapolis, Indiana 46285.
  • Qian M; Takeda, Cambridge, Massachussetts 02139.
  • Tse S; Pfizer Inc., Groton, Connecticut 06340.
  • Yan Z; Genentech, South San Francisco, California 94080.
  • Zamek-Gliszczynski MJ; GlaxoSmithKline, King of Prussia, Pennsylvania 19406.
J Pharm Sci ; 106(12): 3442-3452, 2017 12.
Article en En | MEDLINE | ID: mdl-28927987
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Unión Proteica / Preparaciones Farmacéuticas / Proteínas Sanguíneas / Interacciones Farmacológicas Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Pharm Sci Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Unión Proteica / Preparaciones Farmacéuticas / Proteínas Sanguíneas / Interacciones Farmacológicas Tipo de estudio: Guideline / Prognostic_studies Idioma: En Revista: J Pharm Sci Año: 2017 Tipo del documento: Article